Article info

Download PDFPDF

Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19

Authors

  1. Correspondence to Dr James J DiNicolantonio; jjdinicol{at}gmail.com
View Full Text

Citation

DiNicolantonio JJ, Barroso J, McCarty M
Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19

Publication history

  • Accepted August 25, 2020
  • First published September 6, 2020.
Online issue publication 
September 06, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.